Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification

NCT00183001 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 452

Last updated 2009-02-16

No results posted yet for this study

Summary

The purpose of this study is to determine if supplemental vitamin K will reduce age-related bone loss in elderly men and women above that achieved by supplementation.

Conditions

Interventions

DRUG

Vitamin K

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Arthritis Foundation

    collaborator OTHER
  • USDA Beltsville Human Nutrition Research Center

    collaborator FED
  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Sarah L. Booth, PhD · Tufts Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Completion
2006-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00183001 on ClinicalTrials.gov